Found: 121
Select item for more details and to access through your institution.
How to manage Cushing's disease after failed primary pituitary surgery.
- Published in:
- European Journal of Endocrinology, 2024, v. 191, n. 3, p. R37, doi. 10.1093/ejendo/lvae110
- By:
- Publication type:
- Article
PRAP study—partial versus radical adrenalectomy in hereditary pheochromocytomas.
- Published in:
- European Journal of Endocrinology, 2024, v. 191, n. 3, p. 345, doi. 10.1093/ejendo/lvae108
- By:
- Publication type:
- Article
Hypercoagulability in Cushing's syndrome: incidence, pathogenesis and need for thromboprophylaxis protocols.
- Published in:
- Pituitary, 2022, v. 25, n. 5, p. 746, doi. 10.1007/s11102-022-01261-9
- By:
- Publication type:
- Article
Correction to: Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing's syndrome.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing's syndrome.
- Published in:
- Pituitary, 2021, v. 24, n. 1, p. 104, doi. 10.1007/s11102-020-01103-6
- By:
- Publication type:
- Article
Health-Related Quality of Life in Adrenocortical Carcinoma: Development of the Disease-Specific Questionnaire ACC-QOL and Results from the PROFILES Registry.
- Published in:
- Cancers, 2022, v. 14, n. 6, p. 1366, doi. 10.3390/cancers14061366
- By:
- Publication type:
- Article
Outcomes after Surgical Treatment of Metastatic Disease in the Adrenal Gland; Valuable for the Patient?
- Published in:
- Cancers, 2022, v. 14, n. 1, p. 156, doi. 10.3390/cancers14010156
- By:
- Publication type:
- Article
How to Differentiate Benign from Malignant Adrenocortical Tumors?
- Published in:
- Cancers, 2021, v. 13, n. 17, p. 4383, doi. 10.3390/cancers13174383
- By:
- Publication type:
- Article
Tumor Microenvironment in Adrenocortical Carcinoma: Barrier to Immunotherapy Success?
- Published in:
- Cancers, 2021, v. 13, n. 8, p. 1798, doi. 10.3390/cancers13081798
- By:
- Publication type:
- Article
Evolution of the Mesenteric Mass in Small Intestinal Neuroendocrine Tumours.
- Published in:
- Cancers, 2021, v. 13, n. 3, p. 443, doi. 10.3390/cancers13030443
- By:
- Publication type:
- Article
Development and Internal Validation of a Multivariable Prediction Model for Adrenocortical-Carcinoma-Specific Mortality.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2720, doi. 10.3390/cancers12092720
- By:
- Publication type:
- Article
The PRolaCT studies - a study protocol for a combined randomised clinical trial and observational cohort study design in prolactinoma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Increased Urinary Extracellular Vesicle Sodium Transporters in Cushing Syndrome With Hypertension.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Expression of Contactin 4 Is Associated With Malignant Behavior in Pheochromocytomas and Paragangliomas.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Identification of Mutations in Cell-Free Circulating Tumor DNA in Adrenocortical Carcinoma: A Case Series.
- Published in:
- 2017
- By:
- Publication type:
- journal article
In Vitro Head-to-Head Comparison Between Octreotide and Pasireotide in GH-Secreting Pituitary Adenomas.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Effects of therapy with [<sup>177</sup>Lu-DOTA<sup>0</sup>,Tyr<sup>3</sup>]octreotate on endocrine function.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2009, v. 36, n. 11, p. 1758, doi. 10.1007/s00259-009-1151-8
- By:
- Publication type:
- Article
Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [Lu-DOTA,Tyr]octreotate.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2008, v. 35, n. 4, p. 749, doi. 10.1007/s00259-007-0691-z
- By:
- Publication type:
- Article
Nonmosaic somatic HIF2A mutations associated with late onset polycythemia‐paraganglioma syndrome: Newly recognized subclass of polycythemia‐paraganglioma syndrome.
- Published in:
- Cancer (0008543X), 2019, v. 125, n. 8, p. 1258, doi. 10.1002/cncr.31839
- By:
- Publication type:
- Article
Nonmosaic somatic HIF2A mutations associated with late onset polycythemia-paraganglioma syndrome: Newly recognized subclass of polycythemia-paraganglioma syndrome.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Complex MAX Rearrangement in a Family With Malignant Pheochromocytoma, Renal Oncocytoma, and Erythrocytosis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Major prognostic role of ki67 in localized adrenocortical carcinoma after complete resection.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Parathyroid Hormone-Related Peptide (PTHrP) Secretion by Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): Clinical Features, Diagnosis, Management, and Follow-Up.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Coexpression of Dopamine and Somatostatin Receptor Subtypes in Corticotroph Adenomas.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2009, v. 94, n. 4, p. 1118, doi. 10.1210/jc.2008-2101
- By:
- Publication type:
- Article
Aortic Valve Calcification and Mild Tricuspid Regurgitation But No Clinical Heart Disease after 8 Years of Dopamine Agonist Therapy for Prolactinoma.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2008, v. 93, n. 9, p. 3348, doi. 10.1210/jc.2007-2658
- By:
- Publication type:
- Article
Potent inhibitory effects of type I interferons on human adrenocortical carcinoma cell growth.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Thyroid Hormone Concentrations, Disease, Physical Function, and Mortality in Elderly Men.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2005, v. 90, n. 12, p. 6403, doi. 10.1210/jc.2005-0872
- By:
- Publication type:
- Article
Expression of the Human Glucocorticoid Receptor Splice Variants α, β, and P in Peripheral Blood Mononuclear Leukocytes in Healthy Controls and in Patients with Hyper- and Hypocortisolism.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2005, v. 90, n. 11, p. 6237, doi. 10.1210/jc.2005-1042
- By:
- Publication type:
- Article
The Novel Somatostatin Analog SOM230 Is a Potent Inhibitor of Hormone Release by Growth Hormone- and Prolactin-Secreting Pituitary Adenomas in Vitro.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2004, v. 89, n. 4, p. 1577, doi. 10.1210/jc.2003-031344
- By:
- Publication type:
- Article
A Single-Dose Comparison of the Acute Effects between the New Somatostatin Analog SOM230 and Octreotide in Acromegalic Patients.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2004, v. 89, n. 2, p. 638, doi. 10.1210/jc.2003-031052
- By:
- Publication type:
- Article
Luteinizing Hormone (LH)-Responsive Cushing’s Syndrome: The Demonstration of LH Receptor Messenger Ribonucleic Acid in Hyperplastic Adrenal Cells, which Respond to Chorionic Gonadotropin and Serotonin Agonists in Vitro.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2003, v. 88, n. 1, p. 230, doi. 10.1210/jc.2002-020621
- By:
- Publication type:
- Article
The Role of the IGF2 Methylation Score in Diagnosing Adrenocortical Tumors with Unclear Malignant Potential—Feasibility of Formalin-Fixed Paraffin-Embedded Tissue.
- Published in:
- Biomedicines, 2023, v. 11, n. 7, p. 2013, doi. 10.3390/biomedicines11072013
- By:
- Publication type:
- Article
Influence of Receptor Polymorphisms on the Response to α-Adrenergic Receptor Blockers in Pheochromocytoma Patients.
- Published in:
- Biomedicines, 2022, v. 10, n. 4, p. 896, doi. 10.3390/biomedicines10040896
- By:
- Publication type:
- Article
Targeted Systemic Treatment of Neuroendocrine Tumors: Current Options and Future Perspectives.
- Published in:
- Drugs, 2019, v. 79, n. 1, p. 21, doi. 10.1007/s40265-018-1033-0
- By:
- Publication type:
- Article
Cortisol and Phosphate Homeostasis: Cushing's Syndrome Is Associated With Reversible Hypophosphatemia.
- Published in:
- Frontiers in Endocrinology, 2021, v. 12, p. 1, doi. 10.3389/fendo.2021.733793
- By:
- Publication type:
- Article
Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study.
- Published in:
- Frontiers in Endocrinology, 2021, v. 12, p. 1, doi. 10.3389/fendo.2021.662865
- By:
- Publication type:
- Article
Levoketoconazole in the Treatment of Patients With Cushing's Syndrome and Diabetes Mellitus: Results From the SONICS Phase 3 Study.
- Published in:
- Frontiers in Endocrinology, 2021, v. 11, p. N.PAG, doi. 10.3389/fendo.2021.595894
- By:
- Publication type:
- Article
In vitro glucocorticoid sensitivity is associated with clinical glucocorticoid therapy outcome in rheumatoid arthritis.
- Published in:
- Arthritis Research & Therapy, 2012, v. 14, n. 4, p. 4029, doi. 10.1186/ar4029
- By:
- Publication type:
- Article
Glucocorticoid receptor gene polymorphisms and disease activity during pregnancy and the postpartum period in rheumatoid arthritis.
- Published in:
- Arthritis Research & Therapy, 2012, v. 14, n. 4, p. 4014, doi. 10.1186/ar4014
- By:
- Publication type:
- Article
What's new on the HPA axis?
- Published in:
- Intensive Care Medicine, 2015, v. 41, n. 8, p. 1477, doi. 10.1007/s00134-015-3771-8
- By:
- Publication type:
- Article
Mutational analyses of epidermal growth factor receptor and downstream pathways in adrenocortical carcinoma.
- Published in:
- European Journal of Endocrinology, 2013, v. 169, n. 1, p. 51, doi. 10.1530/EJE-13-0093
- By:
- Publication type:
- Article
Regulation of steroidogenesis in a primary pigmented nodular adrenocortical disease-associated adenoma leading to virilization and subclinical Cushing's syndrome.
- Published in:
- European Journal of Endocrinology, 2013, v. 167, n. 1, p. 67, doi. 10.1530/EJE-12-0594
- By:
- Publication type:
- Article
Serum inhibin pro-&agr;C is a tumor marker for adrenocortical carcinomas.
- Published in:
- European Journal of Endocrinology, 2012, v. 166, n. 2, p. 281, doi. 10.1530/EJE-11-0693
- By:
- Publication type:
- Article
Increased myocardial fibrosis and left ventricular dysfunction in Cushing's syndrome.
- Published in:
- European Journal of Endocrinology, 2012, v. 166, n. 1, p. 27, doi. 10.1530/EJE-11-0601
- By:
- Publication type:
- Article
Limited predictive value of an acute test with subcutaneous octreotide for long-term IGF-I normalization with Sandostatin LAR in acromegaly.
- Published in:
- European Journal of Endocrinology, 2005, v. 153, n. 1, p. 67, doi. 10.1530/eje.1.01935
- By:
- Publication type:
- Article
The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5.
- Published in:
- European Journal of Endocrinology, 2005, v. 152, n. 4, p. 645, doi. 10.1530/eje.1.01876
- By:
- Publication type:
- Article
Epigenetic Mechanisms Modulated by Glucocorticoids With a Focus on Cushing Syndrome.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2024, v. 109, n. 6, p. e1424, doi. 10.1210/clinem/dgae151
- By:
- Publication type:
- Article
Approach to the Patient: Insulinoma.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2024, v. 109, n. 4, p. 1109, doi. 10.1210/clinem/dgad641
- By:
- Publication type:
- Article
Dissecting the In Vitro Efficacy of Octreotide and Cabergoline in GH- and GH/PRL-Secreting Pituitary Tumors.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2023, v. 108, n. 5, p. e98, doi. 10.1210/clinem/dgac675
- By:
- Publication type:
- Article
Peptide Receptor Radionuclide Therapy.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 12, p. 3199, doi. 10.1210/clinem/dgac574
- By:
- Publication type:
- Article